Kennedy Capital Management’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Kennedy Capital Management’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-153,555	Closed	-$3.06M	–	656
2022 Q3	$3.06M	Buy	153,555 +82,793	+117%	+$1.09M	0.09%	351
2022 Q2	$488K	Sell	70,762 -595	-0.8%	-$4.18K	0.01%	542
2022 Q1	$664K	Buy	+71,357	New	+$760K	0.02%	538

Kennedy Capital Management's FMTX Position: Q4 2022 in Review

Kennedy Capital Management sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 153,555 shares — an estimated $3.06M sold.

Kennedy Capital Management first reported a position in FMTX in Q1 2022 and held it in 3 quarters. The position peaked at $3.06M in Q3 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

Kennedy Capital Management reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Kennedy Capital Management sold 153,555 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $3.06M.
Kennedy Capital Management first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q1 2022 and held it in 3 quarters.
Kennedy Capital Management's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $3.06M in Q3 2022.
0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Kennedy Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.